2019 Help me understand this report
ABO‐incompatible living donor liver transplantation without plasma exchange on condition of urgency: Two case reports
Search citation statements
Paper Sections
Select...
Citation Types
0
1
0
Year Published
2020
2020
Publication Types
Select...
1
Relationship
0
1
Authors
Journals
Cited by 1 publication
(1 citation statement)
References 4 publications
0
1
0
“…Rituximab is an anti-CD20 antibody originally introduced to treat B-cell lymphoma, and can absolutely eliminate B lymphocytes before transplantation. These breakthroughs have rendered unnecessary several other strategies of ABOi-LDLT, including plasma exchange (9), splenectomy (10), and even local infusion therapy (11).…”
mentioning
confidence: 99%
“…Rituximab is an anti-CD20 antibody originally introduced to treat B-cell lymphoma, and can absolutely eliminate B lymphocytes before transplantation. These breakthroughs have rendered unnecessary several other strategies of ABOi-LDLT, including plasma exchange (9), splenectomy (10), and even local infusion therapy (11).…”
mentioning
confidence: 99%
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
